BR112015010823A2 - composto de 2-piridona - Google Patents
composto de 2-piridonaInfo
- Publication number
- BR112015010823A2 BR112015010823A2 BR112015010823A BR112015010823A BR112015010823A2 BR 112015010823 A2 BR112015010823 A2 BR 112015010823A2 BR 112015010823 A BR112015010823 A BR 112015010823A BR 112015010823 A BR112015010823 A BR 112015010823A BR 112015010823 A2 BR112015010823 A2 BR 112015010823A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pyridone compound
- pyridone
- tautomer
- solvate
- Prior art date
Links
- -1 2-pyridone compound Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012249792 | 2012-11-13 | ||
| PCT/JP2013/080517 WO2014077235A1 (ja) | 2012-11-13 | 2013-11-12 | ２－ピリドン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015010823A2 true BR112015010823A2 (pt) | 2017-07-11 |
Family
ID=50731146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015010823A BR112015010823A2 (pt) | 2012-11-13 | 2013-11-12 | composto de 2-piridona |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9695148B2 (https=) |
| EP (1) | EP2921489B1 (https=) |
| JP (1) | JP5963025B2 (https=) |
| KR (1) | KR102160841B1 (https=) |
| CN (1) | CN104768944B (https=) |
| AU (1) | AU2013345930B2 (https=) |
| BR (1) | BR112015010823A2 (https=) |
| CA (1) | CA2891406C (https=) |
| DK (1) | DK2921489T3 (https=) |
| ES (1) | ES2641469T3 (https=) |
| HU (1) | HUE034557T2 (https=) |
| IL (1) | IL238701B (https=) |
| IN (1) | IN2015DN03869A (https=) |
| MX (1) | MX361479B (https=) |
| MY (1) | MY173812A (https=) |
| NO (1) | NO2921489T3 (https=) |
| NZ (1) | NZ707832A (https=) |
| PH (1) | PH12015501056B1 (https=) |
| PL (1) | PL2921489T3 (https=) |
| PT (1) | PT2921489T (https=) |
| RU (1) | RU2662157C2 (https=) |
| SG (1) | SG11201503716RA (https=) |
| TW (1) | TWI591064B (https=) |
| WO (1) | WO2014077235A1 (https=) |
| ZA (1) | ZA201503323B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6048533B2 (ja) * | 2014-05-12 | 2016-12-21 | 日産化学工業株式会社 | ２−ピリドン化合物を含有する医薬 |
| KR20170003524A (ko) * | 2014-05-13 | 2017-01-09 | 닛산 가가쿠 고교 가부시키 가이샤 | 2-피리돈 화합물의 제조 방법 |
| AU2019278015B2 (en) | 2018-05-31 | 2024-10-03 | Hua Medicine (Shanghai) Ltd. | Pharmaceutical combination, composition, and combination formulation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275069A (en) | 1979-01-22 | 1981-06-23 | The Upjohn Company | Anti-diabetic 1,2-dihydro-2-oxo-6-alkyl-nicotinic acids |
| PL350669A1 (en) | 1999-03-29 | 2003-01-27 | Hoffmann La Roche | Glucokinase activators |
| US6353111B1 (en) | 1999-12-15 | 2002-03-05 | Hoffmann-La Roche Inc. | Trans olefinic glucokinase activators |
| ES2362949T3 (es) | 2006-06-08 | 2011-07-15 | Eli Lilly And Company | Carboxamidas substituidas como antagonistas del receptor metabotrópico de grupo i. |
| US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
| EA016595B1 (ru) * | 2007-07-17 | 2012-06-29 | Бристол-Маерс Сквибб Компани | Способ модулирования рецептора gpr119, сопряженного с g-белком, и используемые при этом соединения |
| JP2011529483A (ja) | 2008-07-29 | 2011-12-08 | ファイザー・インク | フッ素化ヘテロアリール |
| AU2010327597B2 (en) * | 2009-12-04 | 2014-06-19 | Nissan Chemical Industries, Ltd. | 2-Pyridone compounds |
| JP2013010750A (ja) | 2011-06-02 | 2013-01-17 | Taisho Pharmaceutical Co Ltd | ２−ピリドン化合物を含有する医薬 |
-
2013
- 2013-11-12 DK DK13855534.7T patent/DK2921489T3/en active
- 2013-11-12 NZ NZ707832A patent/NZ707832A/en not_active IP Right Cessation
- 2013-11-12 HU HUE13855534A patent/HUE034557T2/en unknown
- 2013-11-12 US US14/442,157 patent/US9695148B2/en not_active Expired - Fee Related
- 2013-11-12 CN CN201380059272.2A patent/CN104768944B/zh not_active Expired - Fee Related
- 2013-11-12 NO NO13855534A patent/NO2921489T3/no unknown
- 2013-11-12 IN IN3869DEN2015 patent/IN2015DN03869A/en unknown
- 2013-11-12 JP JP2014546982A patent/JP5963025B2/ja not_active Expired - Fee Related
- 2013-11-12 EP EP13855534.7A patent/EP2921489B1/en active Active
- 2013-11-12 PL PL13855534T patent/PL2921489T3/pl unknown
- 2013-11-12 PT PT138555347T patent/PT2921489T/pt unknown
- 2013-11-12 RU RU2015122717A patent/RU2662157C2/ru active
- 2013-11-12 KR KR1020157012117A patent/KR102160841B1/ko not_active Expired - Fee Related
- 2013-11-12 AU AU2013345930A patent/AU2013345930B2/en not_active Ceased
- 2013-11-12 BR BR112015010823A patent/BR112015010823A2/pt not_active Application Discontinuation
- 2013-11-12 ES ES13855534.7T patent/ES2641469T3/es active Active
- 2013-11-12 MY MYPI2015701491A patent/MY173812A/en unknown
- 2013-11-12 CA CA2891406A patent/CA2891406C/en not_active Expired - Fee Related
- 2013-11-12 SG SG11201503716RA patent/SG11201503716RA/en unknown
- 2013-11-12 WO PCT/JP2013/080517 patent/WO2014077235A1/ja not_active Ceased
- 2013-11-12 MX MX2015005884A patent/MX361479B/es active IP Right Grant
- 2013-11-13 TW TW102141288A patent/TWI591064B/zh not_active IP Right Cessation
-
2015
- 2015-05-07 IL IL238701A patent/IL238701B/en active IP Right Grant
- 2015-05-12 PH PH12015501056A patent/PH12015501056B1/en unknown
- 2015-05-13 ZA ZA2015/03323A patent/ZA201503323B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015018738A8 (pt) | compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica | |
| MX2015017861A (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
| EA201690848A1 (ru) | Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4 | |
| BR112015009850A2 (pt) | compostos de piridila substituídos por heteroarila úteis como moduladores de quinase | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| IN2014MN02106A (https=) | ||
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| MX2020011652A (es) | Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn. | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
| BR112014026266A2 (pt) | derivado de quinazolidinadiona | |
| MA40171A (fr) | Dérivés d'azamophinan et leur utilisation | |
| BR112015024075A2 (pt) | compostos de piridinilpirazoloquinolina | |
| EA201692542A1 (ru) | Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы | |
| BR112015030399B8 (pt) | Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3 | |
| BR112012031340A2 (pt) | derivados de cianoquinolina | |
| EA201591815A1 (ru) | Бицикло [2.2.2] кислоты - модуляторы gpr120 | |
| BR112015029348A2 (pt) | inibidores da bace | |
| BR112015026967A8 (pt) | fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica | |
| BR112014026305A2 (pt) | derivado de quinazolidinadiona | |
| MX390763B (es) | Compuestos de tetraciclina | |
| PH12015501386A1 (en) | Tricyclic compounds | |
| MX2016014939A (es) | Derivados de carboxamida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: NISSAN CHEMICAL INDUSTRIES, LTD. (JP) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |